GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Intervacc AB (OSTO:IVACC) » Definitions » Gross Margin %

Intervacc AB (OSTO:IVACC) Gross Margin % : 23.43% (As of Dec. 2023)


View and export this data going back to 2017. Start your Free Trial

What is Intervacc AB Gross Margin %?

Gross Margin % is calculated as gross profit divided by its revenue. Intervacc AB's Gross Profit for the three months ended in Dec. 2023 was kr0.38 Mil. Intervacc AB's Revenue for the three months ended in Dec. 2023 was kr1.63 Mil. Therefore, Intervacc AB's Gross Margin % for the quarter that ended in Dec. 2023 was 23.43%.


The historical rank and industry rank for Intervacc AB's Gross Margin % or its related term are showing as below:

OSTO:IVACC' s Gross Margin % Range Over the Past 10 Years
Min: -172.1   Med: 33.3   Max: 119.18
Current: -172.1


During the past 10 years, the highest Gross Margin % of Intervacc AB was 119.18%. The lowest was -172.10%. And the median was 33.30%.

OSTO:IVACC's Gross Margin % is ranked worse than
96.65% of 746 companies
in the Biotechnology industry
Industry Median: 59.74 vs OSTO:IVACC: -172.10

Intervacc AB had a gross margin of 23.43% for the quarter that ended in Dec. 2023 => Competition eroding margins

The 5-Year average Growth Rate of Gross Margin for Intervacc AB was 0.00% per year.


Intervacc AB Gross Margin % Historical Data

The historical data trend for Intervacc AB's Gross Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Intervacc AB Gross Margin % Chart

Intervacc AB Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Gross Margin %
Get a 7-Day Free Trial Premium Member Only Premium Member Only 23.72 97.13 119.18 34.77 -172.10

Intervacc AB Quarterly Data
Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23
Gross Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -50.88 53.41 42.51 -521.40 23.43

Competitive Comparison of Intervacc AB's Gross Margin %

For the Biotechnology subindustry, Intervacc AB's Gross Margin %, along with its competitors' market caps and Gross Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Intervacc AB's Gross Margin % Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Intervacc AB's Gross Margin % distribution charts can be found below:

* The bar in red indicates where Intervacc AB's Gross Margin % falls into.



Intervacc AB Gross Margin % Calculation

Gross Margin is the percentage of Gross Profit out of sales or Revenue.

Intervacc AB's Gross Margin for the fiscal year that ended in Dec. 2023 is calculated as

Gross Margin % (A: Dec. 2023 )=Gross Profit (A: Dec. 2023 ) / Revenue (A: Dec. 2023 )
=-13.8 / 8.015
=(Revenue - Cost of Goods Sold) / Revenue
=(8.015 - 21.809) / 8.015
=-172.10 %

Intervacc AB's Gross Margin for the quarter that ended in Dec. 2023 is calculated as


Gross Margin % (Q: Dec. 2023 )=Gross Profit (Q: Dec. 2023 ) / Revenue (Q: Dec. 2023 )
=0.4 / 1.626
=(Revenue - Cost of Goods Sold) / Revenue
=(1.626 - 1.245) / 1.626
=23.43 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

A positive Gross Profit is only the first step for a company to make a net profit. The gross profit needs to be big enough to also cover related labor, equipment, rental, marketing/advertising, research and development and a lot of other costs in selling the products.


Intervacc AB  (OSTO:IVACC) Gross Margin % Explanation

Warren Buffett believes that firms with excellent long term economics tend to have consistently higher margins.

Durable competitive advantage creates a high Gross Margin % because of the freedom to price in excess of cost. Companies can be categorized by their Gross Margin %

1. Greater than 40% = Durable competitive advantage
2. Less than 40% = Competition eroding margins
3. Less than 20% = no sustainable competitive advantage
Consistency of Gross Margin is key

Intervacc AB had a gross margin of 23.43% for the quarter that ended in Dec. 2023 => Competition eroding margins


Be Aware

If a company loses its competitive advantages, usually its gross margin declines well before its sales declines. Watching Gross Margin % and Operating Margin % closely helps avoid value trap situations.


Intervacc AB Gross Margin % Related Terms

Thank you for viewing the detailed overview of Intervacc AB's Gross Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Intervacc AB (OSTO:IVACC) Business Description

Traded in Other Exchanges
Address
Vastertorpsvagen 135, Hagersten, Stockholm, SWE, S-129 44
Intervacc AB is a biotechnology company. It develops new vaccines based on recombinant proteins to meet the increasing need for effective vaccines in animal health care. The company through its subsidiary focuses on diagnostics in the Swedish animal health market and offers bacteriological and mycological analyses on the Swedish market.

Intervacc AB (OSTO:IVACC) Headlines

No Headlines